Intratumoral Administration of L19IL2/L19TNF

Clinical trial NCT02076633 · COMPLETED

Trial details

NCT number: NCT02076633
Sponsor: Philogen S.p.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma, Skin

Start date: 2012-12-01
Primary completion: 2015-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.